移植患者中的恶性淋巴瘤：全球经验综述
Malignant lymphomas in transplantation patients: a review of the world experience.
作者信息
Penn I, Starzl T E
出版信息
Int Z Klin Pharmakol Ther Toxikol. 1970 Jan;3(1):49-54.
Abstract
Malignant lymphomas developed in 9 renal homograft recipients treated at widely separated transplantation centers. The development of these tumors appears to be an indirect complication of organ transplantation and/or the measures taken to prevent rejection. A further complication may be an increased incidence of epithelial tumors. It also seems likely that immune paralysis may accelerate the growth of metastases.
摘要
在分布广泛的不同移植中心接受治疗的9例肾移植受者发生了恶性淋巴瘤。这些肿瘤的发生似乎是器官移植和/或为预防排斥反应而采取的措施的间接并发症。另一个并发症可能是上皮肿瘤的发病率增加。免疫麻痹似乎也可能加速转移灶的生长。
相似文献
1
Malignant lymphomas in transplantation patients: a review of the world experience.移植患者中的恶性淋巴瘤：全球经验综述
Int Z Klin Pharmakol Ther Toxikol. 1970 Jan;3(1):49-54.
2
Development of cancer in transplantation patients.
Adv Surg. 1978;12:155-91.
3
Host origin of lymphomas in organ transplant recipients.器官移植受者淋巴瘤的宿主起源
Transplantation. 1979 Mar;27(3):214. doi: 10.1097/00007890-197903000-00016.
4
Malignant lymphomas in transplantation patients.移植患者中的恶性淋巴瘤。
Transplant Proc. 1969 Mar;1(1):106-12.
5
[Lymphomata in patients with kidney transplantation].
Harefuah. 1972 May 15;82(10):474-5.
6
Lymphomas in recipients of renal transplants.肾移植受者中的淋巴瘤
Lancet. 1971 Jul 31;2(7718):258. doi: 10.1016/s0140-6736(71)92589-x.
7
Lymphoma-the most common neoplasia in renal transplant recipients.淋巴瘤——肾移植受者中最常见的肿瘤。
Transplant Proc. 2000 May;32(3):585-6. doi: 10.1016/s0041-1345(00)00900-3.
8
Risk of cancer in renal-transplant recipients.肾移植受者患癌风险
Lancet. 1973 Jul 14;2(7820):55-7. doi: 10.1016/s0140-6736(73)93256-x.
9
Malignant tumors arising de novo in immunosuppressed organ transplant recipients.免疫抑制的器官移植受者新发的恶性肿瘤。
Transplantation. 1972 Oct;14(4):407-17. doi: 10.1097/00007890-197210000-00001.
10
De-novo brain tumours in renal-transplant recipients.肾移植受者的新发脑肿瘤
Lancet. 1971 May 15;1(7707):983-6. doi: 10.1016/s0140-6736(71)91384-5.
引用本文的文献
1
Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.线粒体代谢对慢性淋巴细胞白血病T细胞功能障碍的影响
Front Cell Dev Biol. 2025 Apr 17;13:1577081. doi: 10.3389/fcell.2025.1577081. eCollection 2025.
2
Donor-Derived Hepatic Neuroendocrine Tumor: Pause Before Proceeding With Liver Retransplantation.供体来源的肝神经内分泌肿瘤：在进行肝脏再次移植前需谨慎考虑。
Transplant Direct. 2016 Jun 6;2(7):e88. doi: 10.1097/TXD.0000000000000549. eCollection 2016 Jul.
3
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.接受肾脏替代治疗患者的癌症风险：队列研究的荟萃分析。
Mol Clin Oncol. 2016 Sep;5(3):315-325. doi: 10.3892/mco.2016.952. Epub 2016 Jul 7.
4
Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY).人类肾移植后的长期存活：（特别涉及组织相容性匹配、胸腺切除术、同种异体移植肾小球肾炎、异种抗淋巴细胞球蛋白及受者恶性肿瘤）
Ann Surg. 1970 Sep;172(3):437-72. doi: 10.1097/00000658-197009000-00011.
5
Abscess and fistulae in Crohn's disease.克罗恩病中的脓肿与瘘管
Gut. 1973 Nov;14(11):865-69. doi: 10.1136/gut.14.11.865.
6
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.人类免疫监视的医源性改变及其对恶性肿瘤的影响。
Transplant Rev. 1971;7:112-45. doi: 10.1111/j.1600-065x.1971.tb00465.x.
7
Malignant tumors arising de novo in immunosuppressed organ transplant recipients.免疫抑制的器官移植受者新发的恶性肿瘤。
Transplantation. 1972 Oct;14(4):407-17. doi: 10.1097/00007890-197210000-00001.
8
[Immunology of cancer].[癌症免疫学]
Langenbecks Arch Chir. 1971 Dec;329:264-75. doi: 10.1007/BF01770521.
本文引用的文献
1
Cortisone-induced metastases of adenocarcinoma in mice.可的松诱导的小鼠腺癌转移
Proc Soc Exp Biol Med. 1952 May;80(1):128-31. doi: 10.3181/00379727-80-19544.
2
INFLUENCE OF THYMECTOMY ON TUMOR INDUCTION BY POLYOMA VIRUS IN C57BL MICE.胸腺切除对多瘤病毒在C57BL小鼠中诱发肿瘤的影响。
Proc Soc Exp Biol Med. 1964 Jun;116:323-7. doi: 10.3181/00379727-116-29237.
3
INDUCTION OF RETICULAR TUMOURS IN MICE BY REPEATED ANTIGENIC STIMULATION.通过反复抗原刺激诱导小鼠网状肿瘤
Acta Unio Int Contra Cancrum. 1963;19:657-9.
4
Relation of glucocorticoid activity of steroids to number of metastases.类固醇的糖皮质激素活性与转移灶数量的关系。
Cancer Res. 1962 Dec;22:1297-300.
5
The fate of circulating tumor cells. II. A mechanism of cortisone action in increasing metastases.
Cancer Res. 1962 May;22:501-3.
6
Leukemia and auto-immunization- some possible relationships.白血病与自身免疫——一些可能的关系。
Blood. 1959 Oct;14:1151-8.
7
8
Action of cortisone on disseminated tumor cells after removal of the primary growth.可的松对原发肿瘤切除后播散性肿瘤细胞的作用。
Science. 1955 Jan 21;121(3134):100-1. doi: 10.1126/science.121.3134.100.
9
The action of cortisone on transplanted and induced tumors in mice.可的松对小鼠移植性肿瘤和诱发性肿瘤的作用。
Cancer Res. 1954 Jan;14(1):12-6.
10
Effect of spleen and lymph node removal on adenovirus tumor growth.脾脏和淋巴结切除对腺病毒肿瘤生长的影响。
Arch Surg. 1966 Dec;93(6):971-3. doi: 10.1001/archsurg.1966.01330060115013.
Zotero 插件